Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

December 11, 2014 08:00 ET | Source: Radius Health Inc.

Radius Health Presents RAD1901 Data at 2014 San Antonio Breast Cancer Symposium

WALTHAM, Mass., Dec. 11, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that it presented data from a Phase 1 clinical study on estrogen receptor engagement by the...
November 24, 2014 08:00 ET | Source: Radius Health Inc.

The Journal of Clinical Endocrinology & Metabolism Publishes Radius Health's Phase II Study of the Investigational Drug Abaloparatide in Postmenopausal Women With Osteoporosis

-- Multi-center, multi-national, double-blind, placebo-controlled trial in which postmenopausal women were randomized to receive 24-weeks of treatment with either daily subcutaneous injections of...
November 17, 2014 09:03 ET | Source: Radius Health Inc.

Radius Health's Investigational Drug RAD1901 Selected as One of Informa and Kantar Health's 2014 Top 10 Most Interesting Oncology Projects to Watch

Company selected to present at Informa's Therapeutic Area Partnerships meeting at 1:30 pm ET on Thursday, November 20 in Boston WALTHAM, Mass., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Radius...
November 17, 2014 08:00 ET | Source: Radius Health Inc.

Radius Health to Present at the Jefferies 2014 Global London Healthcare Conference

WALTHAM, Mass., Nov. 17, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) today announced that President and CEO, Robert Ward, is scheduled to present at the Jefferies Global London...
November 10, 2014 17:54 ET | Source: Radius Health Inc.

Radius Health Reports Third Quarter 2014 Financial and Operating Results

WALTHAM, Mass., Nov. 10, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. ("Radius") (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with...
November 03, 2014 08:00 ET | Source: Radius Health Inc.

Radius Health Appoints Industry Veteran Dr. Willard Dere to Board of Directors

WALTHAM, Mass., Nov. 3, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today the appointment of Dr. Willard H. Dere, to its Board of Directors. Dr. Dere was formerly at Amgen,...
October 28, 2014 15:07 ET | Source: Radius Health Inc.

Radius Health to Present at the 2014 BIO-Europe International Partnering Conference

WALTHAM, Mass., Oct. 28, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today that its Vice President, Business Development & Strategy, Geoffrey A. Swire, will present at the...
October 23, 2014 17:41 ET | Source: Radius Health Inc.

Radius Health Sponsors The Cancer Support Community "Elevating the Patient Voice" Symposium in Recognition of National Breast Cancer Awareness Month

WALTHAM, Mass., Oct. 23, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS) announced today it is a sponsor of The Cancer Support Community's symposium, "The Patient Voice: The First Year of...
October 21, 2014 13:07 ET | Source: Radius Health Inc.

Radius Health to Announce Third Quarter 2014 Financial Results, Host Conference Call and Live Webcast on Nov 11, 2014

WALTHAM, Mass., Oct. 21, 2014 (GLOBE NEWSWIRE) -- Radius Health (Nasdaq:RDUS) announced today that it will release its third quarter 2014 financial results on Tuesday, November 11, 2014. In...
October 07, 2014 14:29 ET | Source: Radius Health Inc.

Radius Health, Inc. Announces Closing of Public Offering of Common Stock and Partial Exercise of Underwriters' Option to Purchase Additional Shares

WALTHAM, Mass., Oct. 7, 2014 (GLOBE NEWSWIRE) -- Radius Health, Inc. (Nasdaq:RDUS), a science-driven biopharmaceutical company focused on developing new therapeutics for patients with advanced...